Protein Tyrosine Kinases From Inhibitors to Useful Drugs /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Totowa, NJ :
Humana Press : Imprint: Humana,
2006.
|
| Edición: | 1st ed. 2006. |
| Colección: | Cancer Drug Discovery and Development,
|
| Materias: | |
| Acceso en línea: | https://doi.org/10.1385/1592599621 |
Tabla de Contenidos:
- Protein Tyrosine Kinases as Targets for Cancer and Other Indications
- Inhibitors of Signaling Interfaces
- PI3-Kinase Inhibition
- Src as a Target for Pharmaceutical Intervention
- Activated FLT3 Receptor Tyrosine Kinase as a Therapeutic Target In Leukemia
- JAK Kinases in Leukemias, Lymphomas, and Multiple Myeloma
- Glivec® (Gleevec®, Imatinib, STI571)
- Platelet-Derived Growth Factor
- Structural Biology of Protein Tyrosine Kinases
- Testing of Signal Transduction Inhibitors in Animal Models of Cancer
- Phosphoproteomics in Drug Discovery and Development.